Novo Nordisk gets FDA approval for higher-dose Wegovy HD weight-loss drug
Go back to Novo Nordisk gets FDA approval for higher-dose Wegovy HD weight-loss drug| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.55 +0.67 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $46.80 | 52 Week Low | $32.80 | |||
| Day High | $47.12 | P/E | N/A | |||
| Day Low | $46.44 | EPS | $0.00 | |||
| Volume | 12,680,135 | |||||
